Roy Vagelos, former CEO of Merck @axialxyz
Roy Vagelos, former CEO of Merck @axialxyz
Uploaded May 2024 | Updated September 2026, 2 weeks ago
Roy Vagelos, former CEO of MerckScientist Stories: Michael Inouye, Polygenic risk scores and their use in the clinicScientist Stories: Alfonso Martinez-Arias, On the Self-Engineering of Embryonic Stem CellsScientist Stories: Joe Ecker, DNA methylome dynamicsScientist Stories: Nir Yosef, High-Throughput GenomicsScientist Stories: Oliver Stegle, Genetic Basis Cellular IdentityFounder Stories: Ben Holland, Computational Antibody DiscoveryScientist Stories: Kevin Wu, Learning the Grammar of T-cell receptorsScientist Stories: Trevor Lawley, Early Life MicrobiomesScientist Stories: Sharon Plon, Germline Cancer GenomicsScientist Stories: Andres Floto, Functional Genomics with MLScientist Stories: Richard Gibbs, Mapping Human Genetic Variation
Axial |

Roy Vagelos, former CEO of Merck

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER